DLD develops, markets and provides scientific service for high quality innovative tests for in vitro diagnosis, especially for autoimmune diseases, cardiovascular diseases, cancer diseases and renal dysfunction. The methodology of the tests is chiefly based on RIA and ELISA. DLD stands for innovative products and high level research and development in cooperation with several study groups.
Included in the Export Interest Directory? No
Business Needs: Distributor/Agent/Representative
Products to be exported: Calretinin ELISA: A New Assay for the Detection of Mesothelioma